C92.0 Acute myeloblastic leukaemia [AML] - analogs
| Description «C92.0 Acute myeloblastic leukaemia [AML]» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 20% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 20% Compare C92.5 Acute myelomonocytic leukaemia
- 20% Compare C94 Other leukaemias of specified cell type
- 20% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 20% Compare C95.0 Acute leukaemia of unspecified cell type
- 20% Compare C94.2 Acute megakaryoblastic leukaemia
- 20% Compare C95 Leukaemia of unspecified cell type
- 12% Compare C91.0 Acute lymphoblastic leukaemia [ALL]
- 12% Compare C95.1 Chronic leukaemia of unspecified cell type
- 10% Compare C91.9 Lymphoid leukaemia, unspecified
- 10% Compare C91 Lymphoid leukaemia
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.